Role of multiparametric magnetic resonance imaging for patients under active surveillance for prostate cancer: a systematic review with diagnostic meta-analysis

F Cantiello, GI Russo, S Kaufmann… - Prostate Cancer and …, 2019 - nature.com
Background The use of multiparametric magnetic resonance imaging (mpMRI) in the setting
of patients under active surveillance (AS) is promising. In this systematic-review we aimed to …

What is the best way not to treat prostate cancer?

MS Leapman, PR Carroll - Urologic Oncology: Seminars and Original …, 2017 - Elsevier
Introduction Selective treatment approaches for prostate cancer (PCa) are warranted given
the highly varied nature of the disease and the consequences associated with definitive …

Value of serial multiparametric magnetic resonance imaging and magnetic resonance imaging–guided biopsies in men with low-risk prostate cancer on active …

EHJ Hamoen, CMA Hoeks, DM Somford… - European Urology …, 2019 - Elsevier
Background Active surveillance (AS) aims to reduce overtreatment of low-risk prostate
cancer (PC). Incorporating multiparametric magnetic resonance imaging (mp-MRI) and MR …

Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer

A Fujihara, T Iwata, A Shakir, A Tafuri… - BJU …, 2021 - Wiley Online Library
Objective To investigate the utility of multiparametric magnetic resonance imaging (mpMRI)
in the reassessment and monitoring of patients on active surveillance (AS) for Grade Group …

[HTML][HTML] National consensus quality indicators to assess quality of care for active surveillance in low-risk prostate cancer: An evidence-informed, modified Delphi …

N Timilshina, A Finelli, G Tomlinson… - Canadian Urological …, 2022 - ncbi.nlm.nih.gov
Methods Convenience sampling methods were used to identify an expert panel among
practicing urologists and radiation oncologists across Canada. QI development involved two …

Impact of lesion visibility on transrectal ultrasound on the prediction of clinically significant prostate cancer (Gleason score 3+ 4 or greater) with transrectal ultrasound …

K Garcia-Reyes, HG Nguyen, RJ Zagoria… - The Journal of …, 2018 - auajournals.org
Purpose: The purpose of this study was to estimate the impact of lesion visibility with
transrectal ultrasound on the prediction of clinically significant prostate cancer with …

Confirmatory biopsy of men under active surveillance: extended versus saturation versus multiparametric magnetic resonance imaging/transrectal ultrasound fusion …

P Pepe, S Cimino, A Garufi, G Priolo… - … Journal of Urology, 2017 - Taylor & Francis
Objective: The aim of this study was to evaluate the detection rate for clinically significant
prostate cancer (PCa) after multiparametric magnetic resonance imaging …

Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy

P Pepe, S Cimino, A Garufi, G Priolo… - Archivio Italiano di …, 2016 - pagepressjournals.org
Results: 21/75 (28%) patients were reclassified by SPBx based on upgraded GS≥ 7;
mpMRI lesions PI-RADS 4-5 vs PI-RADS 3-5 diagnosed 9/21 (42.8%) vs 16/21 (76.2%) …

TRUS 及超声造影联合MRI 引导前列腺靶向穿刺的临床研究

韩泽朝, 张宇, 田雅翠, 王庆文 - 河北医科大学学报, 2017 - cqvip.com
目的探讨经直肠超声(transrectal ultrasound, TRUS) 及超声造影联合MRI
引导前列腺靶向穿刺的临床应用价值. 方法对行前列腺穿刺活组织检查并经手术病理证实的187 …

MRI to guide biopsies or avoid biopsies?

JS Winoker, PA Pinto, AR Rastinehad - Current opinion in urology, 2018 - journals.lww.com
Summary mpMRI is an evolving technology with great promise for altering our approach to
prostate cancer diagnosis and surveillance. In conjunction with targeted biopsies, MRI offers …